1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma. Issue 2 (December 2015) Authors: Hegde, Meenakshi; Grada, Zakaria; Pignata, Antonella; Wakefield, Amanda; Fousek, Kristen; Bielamowicz, Kevin; Chow, Kevin; Brawley, Vita; Byrd, Tiara; Gottschalk, Stephen; Mukherjee, Malini; Wels, Winfried; Baker, Matthew; Dotti, Giapietro; Orange, Jordan; Ahmed, Nabil Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. (4th November 2015) Authors: Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros... Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Issue 2 (December 2015) Authors: Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros... Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ErbB2/Her2-specific NK cells for adoptive immunotherapy of glioblastoma. (6th November 2014) Authors: Zhang, Congcong; Burger, Michael; Jennewein, Lukas; Genßler, Sabrina; Grez, Manuel; Tonn, Torsten; Mittelbronn, Michel; Steinbach, Joachim; Wels, Winfried Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Generation and Characterization of Recombinant Vascular Targeting Agents from Hybridoma Cell Lines. (January 2001) Authors: Gottstein, Claudia; Wels, Winfried; Ober, Bertram; Thorpe, Philip E. Journal: Biotechniques Issue: Volume 30:Number 1(2001) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting. Issue 1 (19th January 2021) Authors: Eitler, Jiri; Wotschel, Natalie; Miller, Nicole; Boissel, Laurent; Klingemann, Hans G; Wels, Winfried; Tonn, Torsten Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗